Drugs / BOL-DP-o-04
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04082000 | Apr 2019 → Nov 2020 | diabetic neuropathy | Breath of Life International Pharma Ltd | Terminated | No outcome recorded Stop: Business |
| Phase 1/2 | NCT04145310 | Nov 2018 → Jul 2022 | sciatica | Breath of Life International Pharma Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BOL-DP-o-04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04082000 ↗ |
| Route | Other | “sublingual drops” NCT04145310 ↗ |